載入...
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment
Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to its selective action on proliferating cells, Tofa can offer a way to block T cell activation, without toxic effects on resting cells. Howeve...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3887061/ https://ncbi.nlm.nih.gov/pubmed/24416411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0085463 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|